Advice
Following a full submission.
Oxycodone prolonged release (OxyContin) is accepted for restricted use within NHS Scotland for the treatment of severe non-malignant pain requiring a strong opioid analgesic.
Oxycodone prolonged release is restricted to use in patients in whom controlled release morphine sulphate is ineffective or not tolerated.
Download detailed advice50KB (PDF)
Medicine details
- Medicine name:
- Oxycodone prolonged release tablets 5,10,20,40 and 80mg (OxyContin®)
- SMC ID:
- 197/05
- Indication:
- Severe non-malignant pain requiring a strong opioid
- Pharmaceutical company
- Napp Pharmaceuticals Ltd
- BNF chapter
- Central nervous system
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 12 September 2005